Investing
NovoCure, Synchrony, Twitter, Yum! and More Wednesday Afternoon Analyst Calls
Published:
With the trading day about halfway over, the broad markets were again somewhat mixed. The Dow Jones industrial average was leading the major indexes on the back of solid bank earnings. The Nasdaq saw a small loss despite bitcoin reaching a new high, and the S&P 500 was more or less trading sideways.
24/7 Wall St. is looking at some big analyst calls that we have seen so far on Wednesday. We have included the latest analyst call on each stock, as well as a recent trading history and the consensus targets among analysts.
For those that might have missed it, 24/7 Wall St. had an earlier round of analyst calls on Wednesday that included Alphabet, Facebook, Harley-Davidson, Lowe’s, Snap and more.
Berry Corp. (NASDAQ: BRY): KeyBanc Capital Markets upgraded it from Sector Weight to Overweight with a $9 price target. The shares traded near $6 on Wednesday, in a 52-week trading range of $2.14 to $6.69. The consensus price target is $7.95.
Cardlytics Inc. (NASDAQ: CDLX): Craig Hallum upgraded it from Hold to Buy with a $145 price target. The stock traded near $113 on Wednesday, in a 52-week range of $38.00 to $161.47. It has a consensus price target of $143.25.
Global Blood Therapeutics Inc. (NASDAQ: GBT): SVB Leerink started coverage with an Outperform rating and a $54 price target. The stock traded near $42 on Wednesday, in a 52-week range of $36.49 to $83.69. The consensus analyst target is $82.11.
NovoCure Ltd. (NASDAQ: NVCR): Wedbush downgraded it to Underperform from Neutral and cut its price target to $154 from $159. On Wednesday, the stock traded around $191. The 52-week trading range is $55.40 to $218.09. Its consensus analyst target is $164.88.
OrganiGram Holdings Inc. (NASDAQ: OGI): CIBCdowngraded it to Sector Underperform from Neutral. The shares changed hands around $3 on Wednesday. The 52-week trading range is $1.01 to $6.45.
Synchrony Financial (NYSE: SYF): The Outperform rating at Oppenheimer was lowered to Perform. Shares traded around $41 on Wednesday, in the 52-week range of $14.02 to $43.61. The consensus price target is $48.63.
Atlassian Corp. (NASDAQ: TEAM): Wells Fargo resumed coverage with an Overweight rating and a $270 price target. The consensus price target is $267.00. Shares traded around $240 on Wednesday, in the 52-week range of $139.25 to $262.40.
Twitter Inc. (NYSE: TWTR): Wedbush resumed coverage with a Neutral rating and a $75 price target. The stock traded around $71 on Wednesday. The 52-week trading range is $25.06 to $80.75. Its consensus analyst target is $70.12.
Yum! Brands Inc. (NYSE: YUM): Argus upgraded it from Hold to Buy with a $135 price target. The stock traded near $118 on Wednesday. The 52-week trading range is $76.48 to $118.78. The consensus price target is $113.59.
24/7 Wall St.While oil stocks have rallied off the dreadful lows of last year, heading into the strongest seasonal time for the sector, and taking advantage of recent selling, may set up energy investors for some solid summer gains.
Check out the top billion-dollar holdings at ARK Invest. And find out if the Coinbase IPO is more important than the big bank earnings.
The #1 Thing to Do Before You Claim Social Security (Sponsor)
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
